📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials. (2018)

First Author: Gale RE

Attributed to: Integrating innovative technologies for genotyping and phenotyping in stratified medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2017-08-802157

PubMed Identifier: 29229596

Publication URI: http://europepmc.org/abstract/MED/29229596

Type: Journal Article/Review

Volume: 131

Parent Publication: Blood

Issue: 4

ISSN: 0006-4971